Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Burden of Antimicrobial Resistance: Compared to What?.

Epidemiologic reviews

de Kraker MEA, Lipsitch M.
PMID: 33710259
Epidemiol Rev. 2022 Jan 14;43(1):53-64. doi: 10.1093/epirev/mxab001.

The increased focus on the public health burden of antimicrobial resistance (AMR) raises conceptual challenges, such as determining how much harm multidrug-resistant organisms do compared to what, or how to establish the burden. Here, we present a counterfactual framework...

Cite
de Kraker MEA, Lipsitch M. Burden of Antimicrobial Resistance: Compared to What?. Epidemiol Rev. 2022;43(1):53-64doi: 10.1093/epirev/mxab001.
de Kraker, M. E. A., & Lipsitch, M. (2022). Burden of Antimicrobial Resistance: Compared to What?. Epidemiologic reviews, 43(1), 53-64. https://doi.org/10.1093/epirev/mxab001
de Kraker, Marlieke E A, and Lipsitch, Marc. "Burden of Antimicrobial Resistance: Compared to What?." Epidemiologic reviews vol. 43,1 (2022): 53-64. doi: https://doi.org/10.1093/epirev/mxab001
de Kraker MEA, Lipsitch M. Burden of Antimicrobial Resistance: Compared to What?. Epidemiol Rev. 2022 Jan 14;43(1):53-64. doi: 10.1093/epirev/mxab001. PMID: 33710259.
Copy Download .nbib Format: NLM
Benchmarking a 2018 Toyota Camry 2.5-liter Atkinson Cycle Engine with Cooled-EGR.

SAE International journal of advances and current practices in mobility

Kargul J, Stuhldreher M, Barba D, Schenk C, Bohac S, McDonald J, Dekraker P.
PMID: 32803170
SAE Int J Adv Curr Pract Mobil. 2019;1(2):601-638. doi: 10.4271/2019-01-0249.

As part of the U.S. Environmental Protection Agency's (EPA's) continuing assessment of advanced light-duty automotive technologies in support of regulatory and compliance programs, a 2018 Toyota Camry A25A-FKS 4-cylinder, 2.5-liter, naturally aspirated, Atkinson Cycle engine with cooled exhaust gas...

Cite
Kargul J, Stuhldreher M, Barba D, et al. Benchmarking a 2018 Toyota Camry 2.5-liter Atkinson Cycle Engine with Cooled-EGR. SAE Int J Adv Curr Pract Mobil. 2019;1(2):601-638doi: 10.4271/2019-01-0249.
Kargul, J., Stuhldreher, M., Barba, D., Schenk, C., Bohac, S., McDonald, J., & Dekraker, P. (2019). Benchmarking a 2018 Toyota Camry 2.5-liter Atkinson Cycle Engine with Cooled-EGR. SAE International journal of advances and current practices in mobility, 1(2), 601-638. https://doi.org/10.4271/2019-01-0249
Kargul, John, et al. "Benchmarking a 2018 Toyota Camry 2.5-liter Atkinson Cycle Engine with Cooled-EGR." SAE International journal of advances and current practices in mobility vol. 1,2 (2019): 601-638. doi: https://doi.org/10.4271/2019-01-0249
Kargul J, Stuhldreher M, Barba D, Schenk C, Bohac S, McDonald J, Dekraker P. Benchmarking a 2018 Toyota Camry 2.5-liter Atkinson Cycle Engine with Cooled-EGR. SAE Int J Adv Curr Pract Mobil. 2019;1(2):601-638. doi: 10.4271/2019-01-0249. PMID: 32803170; PMCID: PMC7425626.
Copy Download .nbib Format: NLM
Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options.

Frontiers in medicine

Morel CM, de Kraker MEA, Harbarth S.
PMID: 33954161
Front Med (Lausanne). 2021 Apr 19;8:652638. doi: 10.3389/fmed.2021.652638. eCollection 2021.

As with any health threat, our ability to respond to the emergence and spread of antimicrobial resistance depends on our ability to understand the scale of the problem, magnitude, geographical spread, and trends over time. This is especially true...

Cite
Morel CM, de Kraker MEA, Harbarth S. Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Front Med (Lausanne). 2021;8:652638doi: 10.3389/fmed.2021.652638.
Morel, C. M., de Kraker, M. E. A., Harbarth, S. (2021). Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Frontiers in medicine, 8652638. https://doi.org/10.3389/fmed.2021.652638
Morel, Chantal M, et al. "Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options." Frontiers in medicine vol. 8 (2021): 652638. doi: https://doi.org/10.3389/fmed.2021.652638
Morel CM, de Kraker MEA, Harbarth S. Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Front Med (Lausanne). 2021 Apr 19;8:652638. doi: 10.3389/fmed.2021.652638. eCollection 2021. PMID: 33954161; PMCID: PMC8091962.
Copy Download .nbib Format: NLM
(+)-Germacrene A biosynthesis . The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory .

Plant physiology

de Kraker JW, Franssen MC, de Groot A, Konig WA, Bouwmeester HJ.
PMID: 9701594
Plant Physiol. 1998 Aug;117(4):1381-92. doi: 10.1104/pp.117.4.1381.
Free PMC Article

The leaves and especially the roots of chicory (Cichorium intybus L. ) contain high concentrations of bitter sesquiterpene lactones such as the guianolides lactupicrin, lactucin, and 8-deoxylactucin. Eudesmanolides and germacranolides are present in smaller amounts. Their postulated biosynthesis through...

Cite
de Kraker JW, Franssen MC, de Groot A, et al. (+)-Germacrene A biosynthesis . The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory . Plant Physiol. 1998;117(4):1381-92doi: 10.1104/pp.117.4.1381.
de Kraker JW, Franssen, M. C., de Groot A, Konig, W. A., & Bouwmeester, H. J. (1998). (+)-Germacrene A biosynthesis . The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory . Plant physiology, 117(4), 1381-92. https://doi.org/10.1104/pp.117.4.1381
de Kraker JW, et al. "(+)-Germacrene A biosynthesis . The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory ." Plant physiology vol. 117,4 (1998): 1381-92. doi: https://doi.org/10.1104/pp.117.4.1381
de Kraker JW, Franssen MC, de Groot A, Konig WA, Bouwmeester HJ. (+)-Germacrene A biosynthesis . The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory . Plant Physiol. 1998 Aug;117(4):1381-92. doi: 10.1104/pp.117.4.1381. PMID: 9701594; PMCID: PMC34902.
Copy Download .nbib Format: NLM
Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Borg MA, Scicluna E, De Kraker M, Van de Sande-Bruinsma N, Tiemersma E, Gür D, Ben Redjeb S, Rasslan O, Elnassar Z, Benbachir M, Pieridou Bagatzouni D, Rahal K, Daoud Z, Grundmann H, Monen J.
PMID: 29208166
Euro Surveill. 2006 Jul;11(7):11-12. doi: 10.2807/esm.11.07.00639-en.

Sporadic reports from centres in the south and east of the Mediterranean have suggested that the prevalence of antibiotic resistance in this region appears to be considerable, yet pan-regional studies using comparable methodology have been lacking in the past....

Cite
Borg MA, Scicluna E, De Kraker M, et al. Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project. Euro Surveill. 2006;11(7):11-12doi: 10.2807/esm.11.07.00639-en.
Borg, M. A., Scicluna, E., De Kraker, M., Van de Sande-Bruinsma, N., Tiemersma, E., Gür, D., Ben Redjeb, S., Rasslan, O., Elnassar, Z., Benbachir, M., Pieridou Bagatzouni, D., Rahal, K., Daoud, Z., Grundmann, H., & Monen, J. (2006). Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 11(7), 11-12. https://doi.org/10.2807/esm.11.07.00639-en
Borg, M A, et al. "Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project." Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin vol. 11,7 (2006): 11-12. doi: https://doi.org/10.2807/esm.11.07.00639-en
Borg MA, Scicluna E, De Kraker M, Van de Sande-Bruinsma N, Tiemersma E, Gür D, Ben Redjeb S, Rasslan O, Elnassar Z, Benbachir M, Pieridou Bagatzouni D, Rahal K, Daoud Z, Grundmann H, Monen J. Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project. Euro Surveill. 2006 Jul;11(7):11-12. doi: 10.2807/esm.11.07.00639-en. PMID: 29208166.
Copy Download .nbib Format: NLM
Successful Return to WorkAre Ergonomic Modifications Worth the Cost?.

Work (Reading, Mass.)

Dekraker M.
PMID: 24441010
Work. 1994;4(4):293-4. doi: 10.3233/WOR-1994-4412.

Most of us hold opinions on contemporary issues in work practice, in all its broad dimensions. "Sounding Board" is a regular feature of this publication, designed to provide a forum for expressing such views, whether mainstream or controversial.The opinions...

Cite
Dekraker M. Successful Return to WorkAre Ergonomic Modifications Worth the Cost?. Work. 1994;4(4):293-4doi: 10.3233/WOR-1994-4412.
Dekraker, M. (1994). Successful Return to WorkAre Ergonomic Modifications Worth the Cost?. Work (Reading, Mass.), 4(4), 293-4. https://doi.org/10.3233/WOR-1994-4412
Dekraker, M. "Successful Return to WorkAre Ergonomic Modifications Worth the Cost?." Work (Reading, Mass.) vol. 4,4 (1994): 293-4. doi: https://doi.org/10.3233/WOR-1994-4412
Dekraker M. Successful Return to WorkAre Ergonomic Modifications Worth the Cost?. Work. 1994;4(4):293-4. doi: 10.3233/WOR-1994-4412. PMID: 24441010.
Copy Download .nbib Format: NLM
Progress update from the hippocampal subfields group.

Alzheimer's & dementia (Amsterdam, Netherlands)

Olsen RK, Carr VA, Daugherty AM, La Joie R, Amaral RSC, Amunts K, Augustinack JC, Bakker A, Bender AR, Berron D, Boccardi M, Bocchetta M, Burggren AC, Chakravarty MM, Chételat G, de Flores R, DeKraker J, Ding SL, Geerlings MI, Huang Y, Insausti R, Johnson EG, Kanel P, Kedo O, Kennedy KM, Keresztes A, Lee JK, Lindenberger U, Mueller SG, Mulligan EM, Ofen N, Palombo DJ, Pasquini L, Pluta J, Raz N, Rodrigue KM, Schlichting ML, Lee Shing Y, Stark CEL, Steve TA, Suthana NA, Wang L, Werkle-Bergner M, Yushkevich PA, Yu Q, Wisse LEM.
PMID: 31245529
Alzheimers Dement (Amst). 2019 Jun 13;11:439-449. doi: 10.1016/j.dadm.2019.04.001. eCollection 2019 Dec.

INTRODUCTION: Heterogeneity of segmentation protocols for medial temporal lobe regions and hippocampal subfields on METHODS: Our international working group, funded by the EU Joint Programme-Neurodegenerative Disease Research (JPND), is working toward the production of a reliable, validated, harmonized protocol...

Cite
Olsen RK, Carr VA, Daugherty AM, et al. Progress update from the hippocampal subfields group. Alzheimers Dement (Amst). 2019;11:439-449doi: 10.1016/j.dadm.2019.04.001.
Olsen, R. K., Carr, V. A., Daugherty, A. M., La Joie, R., Amaral, R. S. C., Amunts, K., Augustinack, J. C., Bakker, A., Bender, A. R., Berron, D., Boccardi, M., Bocchetta, M., Burggren, A. C., Chakravarty, M. M., Chételat, G., de Flores, R., DeKraker, J., Ding, S. L., Geerlings, M. I., Huang, Y., Insausti, R., Johnson, E. G., Kanel, P., Kedo, O., Kennedy, K. M., Keresztes, A., Lee, J. K., Lindenberger, U., Mueller, S. G., Mulligan, E. M., Ofen, N., Palombo, D. J., Pasquini, L., Pluta, J., Raz, N., Rodrigue, K. M., Schlichting, M. L., Lee Shing, Y., Stark, C. E. L., Steve, T. A., Suthana, N. A., Wang, L., Werkle-Bergner, M., Yushkevich, P. A., Yu, Q., Wisse, L. E. M. (2019). Progress update from the hippocampal subfields group. Alzheimer's & dementia (Amsterdam, Netherlands), 11439-449. https://doi.org/10.1016/j.dadm.2019.04.001
Olsen, Rosanna K, et al. "Progress update from the hippocampal subfields group." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 11 (2019): 439-449. doi: https://doi.org/10.1016/j.dadm.2019.04.001
Olsen RK, Carr VA, Daugherty AM, La Joie R, Amaral RSC, Amunts K, Augustinack JC, Bakker A, Bender AR, Berron D, Boccardi M, Bocchetta M, Burggren AC, Chakravarty MM, Chételat G, de Flores R, DeKraker J, Ding SL, Geerlings MI, Huang Y, Insausti R, Johnson EG, Kanel P, Kedo O, Kennedy KM, Keresztes A, Lee JK, Lindenberger U, Mueller SG, Mulligan EM, Ofen N, Palombo DJ, Pasquini L, Pluta J, Raz N, Rodrigue KM, Schlichting ML, Lee Shing Y, Stark CEL, Steve TA, Suthana NA, Wang L, Werkle-Bergner M, Yushkevich PA, Yu Q, Wisse LEM. Progress update from the hippocampal subfields group. Alzheimers Dement (Amst). 2019 Jun 13;11:439-449. doi: 10.1016/j.dadm.2019.04.001. eCollection 2019 Dec. PMID: 31245529; PMCID: PMC6581847.
Copy Download .nbib Format: NLM
Warm Weather and Surgical Site Infections: A Meta-analysis.

Plastic and reconstructive surgery. Global open

Sahtoe APH, Duraku LS, van der Oest MJW, Hundepool CA, de Kraker M, Bode LGM, Zuidam JM.
PMID: 34422523
Plast Reconstr Surg Glob Open. 2021 Jul 27;9(7):e3705. doi: 10.1097/GOX.0000000000003705. eCollection 2021 Jul.

Seasonal variability, in terms of warm weather, has been demonstrated to be a significant risk factor for surgical site infections (SSIs). However, this remains an underexposed risk factor for SSIs, and many clinicians are not aware of this. Therefore,...

Cite
Sahtoe APH, Duraku LS, van der Oest MJW, et al. Warm Weather and Surgical Site Infections: A Meta-analysis. Plast Reconstr Surg Glob Open. 2021;9(7):e3705doi: 10.1097/GOX.0000000000003705.
Sahtoe, A. P. H., Duraku, L. S., van der Oest, M. J. W., Hundepool, C. A., de Kraker, M., Bode, L. G. M., & Zuidam, J. M. (2021). Warm Weather and Surgical Site Infections: A Meta-analysis. Plastic and reconstructive surgery. Global open, 9(7), e3705. https://doi.org/10.1097/GOX.0000000000003705
Sahtoe, Anouschka P H, et al. "Warm Weather and Surgical Site Infections: A Meta-analysis." Plastic and reconstructive surgery. Global open vol. 9,7 (2021): e3705. doi: https://doi.org/10.1097/GOX.0000000000003705
Sahtoe APH, Duraku LS, van der Oest MJW, Hundepool CA, de Kraker M, Bode LGM, Zuidam JM. Warm Weather and Surgical Site Infections: A Meta-analysis. Plast Reconstr Surg Glob Open. 2021 Jul 27;9(7):e3705. doi: 10.1097/GOX.0000000000003705. eCollection 2021 Jul. PMID: 34422523; PMCID: PMC8376315.
Copy Download .nbib Format: NLM
Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.

JAC-antimicrobial resistance

Dramowski A, Ong'ayo G, Rehman AM, Whitelaw A, Labi AK, Obeng-Nkrumah N, Ndir A, Magwenzi MT, Onyedibe K, Wolkewitz M, de Kraker MEA, Scott JAG, Aiken AM.
PMID: 34228033
JAC Antimicrob Resist. 2021 Mar 23;3(1):dlab037. doi: 10.1093/jacamr/dlab037. eCollection 2021 Mar.

[This corrects the article DOI: 10.1093/jacamr/dlaa130.].

Cite
Dramowski A, Ong'ayo G, Rehman AM, et al. Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC Antimicrob Resist. 2021;3(1):dlab037doi: 10.1093/jacamr/dlab037.
Dramowski, A., Ong'ayo, G., Rehman, A. M., Whitelaw, A., Labi, A. K., Obeng-Nkrumah, N., Ndir, A., Magwenzi, M. T., Onyedibe, K., Wolkewitz, M., de Kraker, M. E. A., Scott, J. A. G., & Aiken, A. M. (2021). Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC-antimicrobial resistance, 3(1), dlab037. https://doi.org/10.1093/jacamr/dlab037
Dramowski, Angela, et al. "Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study." JAC-antimicrobial resistance vol. 3,1 (2021): dlab037. doi: https://doi.org/10.1093/jacamr/dlab037
Dramowski A, Ong'ayo G, Rehman AM, Whitelaw A, Labi AK, Obeng-Nkrumah N, Ndir A, Magwenzi MT, Onyedibe K, Wolkewitz M, de Kraker MEA, Scott JAG, Aiken AM. Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC Antimicrob Resist. 2021 Mar 23;3(1):dlab037. doi: 10.1093/jacamr/dlab037. eCollection 2021 Mar. PMID: 34228033; PMCID: PMC8210008.
Copy Download .nbib Format: NLM
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.

Critical care (London, England)

Damonti L, Kronenberg A, Marschall J, Jent P, Sommerstein R, De Kraker MEA, Harbarth S, Gasser M, Buetti N.
PMID: 34809698
Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z.

BACKGROUND: Evidence about the impact of the pandemic of COVID-19 on the incidence rates of blood cultures contaminations and bloodstream infections in intensive care units (ICUs) remains scant. The objective of this study was to investigate the nationwide epidemiology...

Cite
Damonti L, Kronenberg A, Marschall J, et al. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021;25(1):403doi: 10.1186/s13054-021-03814-z.
Damonti, L., Kronenberg, A., Marschall, J., Jent, P., Sommerstein, R., De Kraker, M. E. A., Harbarth, S., Gasser, M., & Buetti, N. (2021). The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Critical care (London, England), 25(1), 403. https://doi.org/10.1186/s13054-021-03814-z
Damonti, Lauro, et al. "The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study." Critical care (London, England) vol. 25,1 (2021): 403. doi: https://doi.org/10.1186/s13054-021-03814-z
Damonti L, Kronenberg A, Marschall J, Jent P, Sommerstein R, De Kraker MEA, Harbarth S, Gasser M, Buetti N. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z. PMID: 34809698; PMCID: PMC8607066.
Copy Download .nbib Format: NLM
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Fröhlich GM, De Kraker MEA, Abbas M, Keiser O, Thiabaud A, Roelens M, Cusini A, Flury D, Schreiber PW, Buettcher M, Corti N, Vuichard-Gysin D, Troillet N, Sauser J, Gaudenz R, Damonti L, Balmelli C, Iten A, Widmer A, Harbarth S, Sommerstein R.
PMID: 34991775
Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2001848.

BackgroundSince the onset of the COVID-19 pandemic, the disease has frequently been compared with seasonal influenza, but this comparison is based on little empirical data.AimThis study compares in-hospital outcomes for patients with community-acquired COVID-19 and patients with community-acquired influenza...

Cite
Fröhlich GM, De Kraker MEA, Abbas M, et al. Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro Surveill. 2022;27(1)doi: 10.2807/1560-7917.ES.2022.27.1.2001848.
Fröhlich, G. M., De Kraker, M. E. A., Abbas, M., Keiser, O., Thiabaud, A., Roelens, M., Cusini, A., Flury, D., Schreiber, P. W., Buettcher, M., Corti, N., Vuichard-Gysin, D., Troillet, N., Sauser, J., Gaudenz, R., Damonti, L., Balmelli, C., Iten, A., Widmer, A., Harbarth, S., & Sommerstein, R. (2022). Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(1), . https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848
Fröhlich, Georg Marcus, et al. "Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19." Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin vol. 27,1 (2022). doi: https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848
Fröhlich GM, De Kraker MEA, Abbas M, Keiser O, Thiabaud A, Roelens M, Cusini A, Flury D, Schreiber PW, Buettcher M, Corti N, Vuichard-Gysin D, Troillet N, Sauser J, Gaudenz R, Damonti L, Balmelli C, Iten A, Widmer A, Harbarth S, Sommerstein R. Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro Surveill. 2022 Jan;27(1). doi: 10.2807/1560-7917.ES.2022.27.1.2001848. PMID: 34991775.
Copy Download .nbib Format: NLM
Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters.

JAMA internal medicine

Buetti N, Abbas M, Pittet D, de Kraker MEA, Teixeira D, Chraiti MN, Sauvan V, Sauser J, Harbarth S, Zingg W.
PMID: 34533191
JAMA Intern Med. 2021 Nov 01;181(11):1471-1478. doi: 10.1001/jamainternmed.2021.5345.

IMPORTANCE: Peripheral intravenous catheters (PVCs) are the most frequently used indwelling devices in hospitals worldwide. Peripheral intravenous catheter bloodstream infections (PVC-BSIs) are rare, but severe and preventable, adverse events.OBJECTIVE: To investigate the incidence of PVC-BSIs after changing the policy...

Cite
Buetti N, Abbas M, Pittet D, et al. Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters. JAMA Intern Med. 2021;181(11):1471-1478doi: 10.1001/jamainternmed.2021.5345.
Buetti, N., Abbas, M., Pittet, D., de Kraker, M. E. A., Teixeira, D., Chraiti, M. N., Sauvan, V., Sauser, J., Harbarth, S., & Zingg, W. (2021). Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters. JAMA internal medicine, 181(11), 1471-1478. https://doi.org/10.1001/jamainternmed.2021.5345
Buetti, Niccolò, et al. "Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters." JAMA internal medicine vol. 181,11 (2021): 1471-1478. doi: https://doi.org/10.1001/jamainternmed.2021.5345
Buetti N, Abbas M, Pittet D, de Kraker MEA, Teixeira D, Chraiti MN, Sauvan V, Sauser J, Harbarth S, Zingg W. Comparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters. JAMA Intern Med. 2021 Nov 01;181(11):1471-1478. doi: 10.1001/jamainternmed.2021.5345. PMID: 34533191; PMCID: PMC8561330.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries